Core Viewpoint - The article discusses the effectiveness of Tirzepatide, a dual agonist of GIP and GLP-1 receptors, in weight loss, highlighting its clinical trial results and personal success stories from various individuals who have used the drug for weight management [4][6][12]. Group 1: Clinical Research Findings - Tirzepatide has shown significant weight loss results comparable to bariatric surgery in a clinical trial involving 2,539 adults with obesity-related complications, where participants lost an average of 16.1 kg, 22.2 kg, and 23.6 kg in different dosage groups over 72 weeks, compared to a 2.4 kg loss in the placebo group [4]. Group 2: Personal Success Stories - Dan Yongping reported a weight loss of 15 pounds (approximately 13.6 kg) after using Tirzepatide for two and a half months, noting improvements in his blood lipid levels without significant side effects [6]. - Whoopi Goldberg shared her experience of losing nearly double her weight since starting Tirzepatide, emphasizing its positive impact on her health [7]. - Lauren Manzo, after using Tirzepatide, lost 30 pounds (approximately 27.2 kg) and stated that the drug was more effective than other weight loss methods, even better than weight loss surgery [11]. - Charles Barkley mentioned a weight loss of 65 pounds (approximately 58.9 kg) while using Tirzepatide, highlighting the challenges he faced with traditional weight loss methods [12][14].
盘点使用礼来替尔泊肽瘦下来的名人:怎么他们都瘦了这么多?
GLP1减重宝典·2026-01-01 08:32